{"id":"W4388033556","doi":"10.1038/s41591-023-02660-6","title":"Association between pathologic response and survival after neoadjuvant therapy in lung cancer","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; McGill University Health Centre","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; National Institutes of Health; Ono Pharmaceutical; Canadian Association of Thoracic Surgeons; G1 Therapeutics; Genentech; F-star Therapeutics; Regeneron Pharmaceuticals; U.S. Department of Defense; Sanofi; LUNGevity Foundation; Society for Immunotherapy of Cancer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Mark Foundation For Cancer Research; Mesothelioma Applied Research Foundation; Pfizer; Amgen","keywords":"Medicine; Lung cancer; Neoadjuvant therapy; Nivolumab; Oncology; Internal medicine; Chemotherapy; Hazard ratio; Cancer; Response Evaluation Criteria in Solid Tumors; Pathology; Progressive disease; Immunotherapy; Confidence interval; Breast cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001652496,0.0001602085,0.0002967109,0.0001903779,0.0001277996,0.0003523892,0.0001691023,0.0002670259,0.0007151605],"category_scores_gemma":[0.002892201,0.000100834,0.0004693152,0.0002286217,0.0002050544,0.0002598793,0.0002133517,0.0005080284,0.0001376444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000346768,"about_ca_system_score_gemma":0.0002855618,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005560539,"about_ca_topic_score_gemma":0.00138927,"domain_scores_codex":[0.9995308,0.0002282996,0.00004068675,0.00007282726,0.00007656076,0.00005079587],"domain_scores_gemma":[0.9977224,0.0009753845,0.0007592135,0.0001589493,0.0001367555,0.0002472586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01329045,0.0002171672,0.9613936,0.00005860884,0.0002481696,0.00008208895,0.0000322553,0.001209808,0.002172951,0.0000494184,0.000321245,0.02092431],"study_design_scores_gemma":[0.00009554369,0.002354049,0.9931431,0.00001297961,0.0001813984,0.000251782,0.00003454283,0.002505284,0.0007248347,0.0001634889,0.0005248908,0.000007964993],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981805,0.0008368756,0.0001935966,0.00008702689,0.00001344272,0.00001118593,0.0001772342,0.000009897416,0.0004902885],"genre_scores_gemma":[0.9993004,0.0001029314,0.00009227607,0.00003380957,0.00001135768,0.000008594906,0.0002770719,0.000002035563,0.0001716467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001652496,"threshold_uncertainty_score":0.008739352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01404497636871023,"score_gpt":0.3485324132110651,"score_spread":0.3344874368423549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}